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Background:Metacaspases are multifunctional cysteine peptidases.
Results: Trypanosoma bruceimetacaspase 4 is a catalytically inactive metacaspase homologue required for parasite virulence,
which interacts with an active parasite metacaspase during release from the cell.
Conclusion:Metacaspase 4 is a pseudopeptidase virulence factor.
Significance: Extracellular release and proteolytic processing provide novel insights into metacaspase function.
Metacaspases are caspase family cysteine peptidases found in
plants, fungi, and protozoa but not mammals. Trypanosoma
brucei is unusual in having five metacaspases (MCA1–MCA5),
of which MCA1 and MCA4 have active site substitutions, mak-
ing thempossible non-enzymatic homologues. Here we demon-
strate that recombinantMCA4 lacks detectable peptidase activ-
ity despite maintaining a functional peptidase structure. MCA4
is expressed primarily in the bloodstream form of the parasite
and associates with the flagellar membrane via dual myristoyla-
tion/palmitoylation. Loss of functionphenotyping revealed crit-
ical roles for MCA4; rapid depletion by RNAi caused lethal dis-
ruption to the parasite’s cell cycle, yet the generation of MCA4
null mutant parasites (mca4) was possible.mca4 had normal
growth in axenic culture but markedly reduced virulence in
mice. Further analysis revealed that MCA4 is released from the
parasite and is specifically processed by MCA3, the only meta-
caspase that is both palmitoylated and enzymatically active.
Accordingly, we have identified that the multiple metacaspases
in T. brucei form amembrane-associated proteolytic cascade to
generate a pseudopeptidase virulence factor.
Metacaspases (MCAs)2 are clan CD, family C14B, cysteine
peptidases identified in plants, fungi, and protozoa (1). They are
predicted to be structurally similar to caspases with a caspase/
hemoglobinase fold and a canonical histidine and cysteine dyad
in the active site (1).MCAs differ fromcaspases in that they lack
Asp specificity, having a strict arginine or lysine substrate spec-
ificity, and many are activated by calcium (2–4). Many MCAs
undergo autocatalytic processing of the zymogen to produce a
mature enzyme, although this processing is not necessarily
required for enzymatic activity (2, 4, 5). The natural targets of
MCAs are uncertain, with the proteolytic cleavage of Picea
abiesTudor staphylococcal nuclease by theMCAmcII-Pa dur-
ing embryogenesis and induced programmed cell death being
the only in vivo action reported to date (6).
A seminal study that identified the Saccharomyces cerevisiae
MCA (Yca1) as a positive regulator of program cell death (7)
sparked great interest and paved the way for many subsequent
descriptions of additional pro-death roles for MCAs (8). How-
ever, sustained research on MCAs of various organisms has
revealed that they represent a functionally diverse family of
peptidases. The single MCAs of S. cerevisiae and Leishmania
major apparently harbor a capacity formultifunctionality. Yca1
is implicated in both cell cycle regulation (9) and the clearance
of insoluble protein aggregates (10), whereas the MCA of
L. major is required for cell cycle progression (11) in addition to
having a role in PCD induced by oxidative stress (12). Further-
more, the antagonistic relationship of twoArabidopsis thaliana
MCAs in the hypersensitive response cell death pathway
(AtMC1 promotes cell death, whereas AtMC2 functions as a
negative regulator) reveals the potential of MCAs for complex
connections in key regulatory processes (13).
Trypanosoma brucei unusually has five metacaspase genes
(MCA1 to MCA5), only three of which (MCA2, MCA3, and
MCA5) encode proteins with the canonical histidine-cysteine
catalytic dyad and are therefore predicted to be catalytically
active (14, 15). Investigation into these MCAs revealed collec-
tive essentiality for bloodstream form parasites; simultaneous
RNAi depletion caused rapid cell death attributed to accumu-
lation of abnormal cell types resulting from a precytokinesis
defect (16). Despite this severe phenotype resulting fromRNAi,
triple null mutant parasites (mca2/3mca5) were generated
and had similar growth in axenic culture and mice as in wild
type parasites. Although questions remain regarding the pre-
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cise role of theseMCAs, it appears that they are not required for
prostaglandin D2-induced cell death (16). However, the three
MCAs were found to be associated with RAB11-positive endo-
somes, although they are not necessary for the known recycling
processes performed by these endosomes (16). Deciphering the
nature of this association could be pivotal to elucidating the
main function(s) of these MCAs.
An intriguing aspect of the T. bruceiMCA family is the pres-
ence of the two genes predicted to encode catalytically inactive
proteins; MCA1 lacks both the histidine and cysteine of the
expected active site dyad, whereas MCA4 has a serine in place
of the usual catalytic cysteine (14, 15). Substitutions within the
catalytic center of enzyme homologues are widespread across
protozoan and metazoan proteomes, and some non-enzymatic
homologues have been shown to play key regulatory roles (17).
Indeed, regulation of some peptidases is known to occur
through related inactive homologues. For example, the activity
of caspase-8 in the mammalian extrinsic apoptotic pathway is
regulated by direct interaction with cFLIPL (cellular FLICE-like
inhibitory protein long form), an inactive caspase-8 homologue
(18). Also, growth factor signaling that is dependent on the
intramembrane rhomboid peptidases is controlled by iRhoms
(inactive rhomboid homologues) through substrate sequestra-
tion and subsequent removal via endoplasmic reticulum degra-
dation (19). However, not all atypical active site configurations
preclude peptidase activity, with mixed catalytic type pepti-
dases also capable of proteolysis. The poliovirus type picornain
C3 peptidases are instrumental in processing expressed viral
proteins with proteolytic activity derived from a cysteine
nucleophile operating within a classical serine peptidase fold
(20). To date, no proteins have been identified with proteolytic
activity derived from a serine nucleophile in a caspase fold.
Thus, several possible roles for MCA4 could be envisaged,
and we undertook a detailed characterization of the enzyme
with the aim of elucidating the part it plays as a member of the
T. brucei MCA family. We found that despite the potentially
catalytic serine residue in the MCA4 active site, the recombi-
nant enzyme lacked peptidase activity toward a combinatorial
peptide library and the specific activity towardArg/Lys residues
characteristic ofmetacaspases and thus is a pseudopeptidase. In
addition, reverse genetics revealed MCA4 to have roles in both
cell cycle progression and parasite virulence during mamma-
lian infection. Moreover, we show that the membrane-associ-
ated MCA4 is specifically processed during its release by the
palmitoylated and thereforemembrane-boundMCA3 and thus
that they appear to comprise a MCA proteolytic cascade.
EXPERIMENTAL PROCEDURES
Plasmids—Unless otherwise stated, all PCRs used T. brucei
(strain 427) genomic DNA as an amplification template, and all
oligonucleotide sequences are listed in supplemental Table S1.
ForMCA4 protein expression, the coding sequence was ampli-
fied using OL2329 and OL2330 and cloned into the pET-
28a() (Novagen) using NdeI and XhoI restriction sites, creat-
ing pGL1697. MCA4S219C protein expression plasmid was
produced by site-directed mutagenesis of MCA4 in pGL1697
using OL2605 and OL2606. For the MCA4 RNAi plasmid, a
unique 469-bp fragment was identified by TrypanoFAN:RNAit
(available on the World Wide Web), amplified using OL2312
andOL2313, and cloned intoHindIII andBamHI sites in p2T7ti
(21), creating pGL1695. For transfection into T. brucei,
pGL1695 was digested with NotI. For deletion of the MCA4
locus, the 5- and 3-flanks of theMCA4ORFwere amplified by
PCR using the primer pair OL3245 (NotI) and OL3246 (XbaI)
and the primer pair OL3247 (ApaI) and OL3248 (ApaI and
XhoI), respectively. Using NotI/XbaI and ApaI/XhoI, the 5-
and 3-flanks were sequentially ligated into pGL1689, creating
the NEO MCA4 knock-out construct named pGL1986.
Exchange of resistance genes was achieved by excising a HYG
gene from pGL1688 using BmgBI and BglII and cloning into
pGL1986 predigested with BmgBI and BglII, generating
pGL1985, the HYG MCA4 knock-out construct. For transfec-
tion into T. brucei, pGL1986 and pGL1985 were digested with
NotI and XhoI.
The ectopic re-expression of MCA4 was achieved by modi-
fication of p2628 (22). First, the following primer pairs were
used for site-directed mutagenesis to introduced NdeI
(OL3047, OL3048) and BclI (OL3046, OL3055) restriction sites
flanking the HYG gene, thereby allowing replacement with a
BSD gene, cloned from pGL1466 using OL3049 and OL3050.
The resulting construct was digested with XhoI and BamHI
(removing the yellow fluorescent protein (YFP) coding
sequence), and the MCA4 gene amplified using OL3403 and
OL3404 was cloned in producing pGL2067. For the ectopic
expression of MCA4-YFP, the same BSD re-expression con-
struct was digestedwithHindIII and BamHI, allowing insertion
of MCA4 cloned without the stop codon using OL3397 and
OL3398 to create pGL2132. For re-expression of mutant forms
ofMCA4, pGL2067was subjected to site-directedmutagenesis.
To investigate MCA4 membrane association, a cytosolic
MCA4 mutant was generated by removing the predicted
N-myristoylation site, using OL3768 and OL3769, creating
MCA4G2A. The active site mutant MCA4S219C was produced
usingOL2605 andOL2606. All site-directedmutagenesis alter-
ations were made using the QuikChange mutagenesis kit
(Stratagene) according to the manufacturer’s instructions and
confirmed by DNA sequencing.
Parasites—T. brucei Lister 427 was grown in culture as a
bloodstream form to amaximum cell density of 1 106ml1 at
37 °C in 5% carbon dioxide in HMI-9 medium supplemented
with 10% heat-inactivated fetal calf serum, 10% serum plus, and
0.5g/ml penicillin-streptomycin solution (Sigma). The procy-
clic formwas grown to amaximum cell density of 1 107ml1
at 27 °C in 5% carbon dioxide in SDM-79 medium supple-
mented with 10% FCS and 0.5 g/ml penicillin-streptomycin
solution (Sigma). The genetic knock-out of MCA4 was per-
formed in bloodstream formT. brucei 427. The tripleMCAnull
mutant cell line (mca2/3mca5) was generated and charac-
terized previously (16). For animal infection assays, 1  105
cultured parasites were inoculated into ICR mice by intraperi-
toneal injection, and the parasitemia was monitored daily by
hemocytometer cell count ofmouse blood taken froma tail vein
diluted in 0.83% ammonium chloride. For infection experi-
ments, groups of four mice were infected with trypanosomes
taken directly from the same donor mouse.
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T. brucei Transfection—1 107mid-log cells were harvested
by centrifugation at 1500 g for 10min at 37 °C. The cell pellet
was resuspended in 100l of HumanTCell Nucleofector Solu-
tion (Lonza), transferred to an electroporation cuvette, mixed
with 10 g of linearized DNA, and pulsed once on program
X-001 using theHumanTCell Nucleofectormachine (Amaxa).
After overnight recovery, selection of clones was achieved by
limiting dilution with appropriate antibiotics 5 g/ml hygro-
mycin B (Calbiochem), 2.5 g/ml G418 (Calbiochem), 2.5
g/ml phleomycin (InvivoGen), and 10 g/ml blasticidin (Cal-
biochem). RNAi analysis and the tetracycline-induced expres-
sion of tagged transgenes were performed in bloodstream form
427 13-90 and procyclic form 427 29-13 cell lines (23). To
induce RNAi or transgene expression, 1g/ml tetracycline was
added to the culture medium, with cells reseeded at 1  105
ml1 every 24 h.
Fluorescence-activated Cell Sorting (FACS)—To analyze the
DNA content of T. brucei, cells were fixed overnight in 70%
methanol, 30% PBS; washed in 10 ml of PBS; resuspended in 1
ml of PBS supplemented with 10 g/ml propidium iodide
(Sigma), 10 g/ml RNase A (Sigma); and incubated at 37 °C for
45 min in the dark. FACS analysis was performed on a BD Bio-
sciences FACSCalibur. For each sample, 10,000 events (cells)
were analyzed. Data interpretation was performed using the
CellQuestPro software (BD Biosciences).
Recombinant Protein; Expression and Purification—The
MCA4 protein expression vector (pGL1697) was transformed
into BL21 Rosetta Escherichia coli (Stratagene), and bacteria
were grown in Overnight Express TB medium (Novagen) for
16 h and lysed in bacterial protein extraction reagent (Pierce)
supplemented with 10g/ml DNase I (Sigma). HIS-MCA4was
purified by immobilizedmetal ion affinity chromatography on a
column packed with Metal Chelate-20 (Poros). MCA4 was
eluted in 1-ml fractions using 50 mM NaH2PO4, 300 mM NaCl,
0.5 M imidazole, pH 8.0, and then buffer-exchanged into 50mM
Tris, pH 8, using a PD10 column (GE Healthcare), and 150 mM
NaCl was subsequently added.
Antibody Production—Purified recombinant MCA4 was
used as an antigen to raise a polyclonal antibody. Two chickens
were immunized with recombinant MCA4 (four 250-l inocu-
lations of 1 g/ml protein over 4 months) at the Scottish
National Blood Transfusion Service (Penicuik, UK). Total IgY
was purified from egg yolks using the Eggcellent IgY Purifica-
tion kit (Pierce) and then affinity-purified against recombinant
MCA4 immobilized on AminoLink coupling gel (Pierce)
according to the manufacturer’s instructions.
Immunoblotting—Whole cell extracts and purified proteins
were mixed with LDS sample buffer (Invitrogen), denatured by
heating at 100 °C for 4 min, and then electrophoresed on 12%
(w/v) SDS-PAGE. Gels were either stained with Coomassie
Brilliant Blue R-250 (2.5% (w/v)), 45% (v/v) methanol, 10% ace-
tic acid or transferred to nitrocellulose membrane (Hybond-C,
Amersham Biosciences) for Western blotting. Primary anti-
bodies againstMCA4, EF-1 (Millipore), and BiP (endoplasmic
reticulum hsp70, binding protein) (gift from J.D. Bangs (Uni-
versity ofWisconsin,Madison,WI)) were used at 1:800, 1:2000,
and 1:15000, respectively. HRP-conjugated anti-chicken (Invit-
rogen) was used at 1:4000, and anti-mouse (Promega), anti-
rabbit (Promega), and anti-sheep (Santa Cruz Biotechnology,
Inc., SantaCruz, CA)were used at 1:5000. The cellular fraction-
ation was verified using antibodies specific to the cytoskeletal
protein -tubulin (24) (KMX-1 monoclonal, Millipore) diluted
1:10,000 and the cytoplasmic protein oligopeptidase B diluted
1:1000 (25–27). Chemiluminescence detection was with the
SuperSignal system or Novex ECL (Invitrogen).
Enzyme Assays—For autocatalytic processing, 10 g of puri-
fied recombinant MCA4 or MCA4S219C was incubated in a
reaction buffer (50 mM Tris-HCl, pH 8, 150 mM NaCl, 5 mM
DTT)with andwithout 10mMCaCl2 for 1 h at 37 °C. ForMCA3
autocatalytic processing, 5 g of recombinant enzyme was
incubated in the described buffer supplemented with 1 mM
CaCl2. The extent of autocatalytic processingwasmonitored by
SDS-PAGE. For MCA2 processing of MCA4, 10 g of purified
MCA4 was incubated with increasing amounts of purified
recombinantMCA2 (0, 1, 10, and 100 ng) in reaction buffer (50
mMTris-HCl, pH8, 150mMNaCl, 5mMDTT, 10mMCaCl2) for
1 h at 37 °C. The extent of processing was monitored by
SDS-PAGE.
Fluorogenic Enzyme Assays—Proteolytic activity of purified
recombinant protein was assessed by measuring the hydrolysis
of synthetic fluorogenic substrates. All assays were run in clear
bottom 96-well plates and typically contained the following
components: 2 g of purified enzyme, reaction buffer (50 mM
Tris-HCl, pH 8, 150 mM NaCl, 5 mM DTT, and 10 mM CaCl2),
10 M substrate (e.g. benzyloxycarbonyl (Z)-RR-7-amino-4-
methylcoumarin (AMC)) and distilled water to 200 l. All
assays were run in triplicate and included “no-enzyme” con-
trols. Fluorescence was read in an EnVision Multilabel Reader
(PerkinElmer Life Sciences) at an excitationwavelength (Ex) of
355 nm and emission wavelength (Em) of 460 nm using the
general mirror. Specific activities were calculated using an
AMC standard. A positional scanning combinatorial library
was used to confirm the lack of MCA4 activity, Abz-
GXXZXXQ-EDDnp (where Abz is ortho-aminobenzoic acid,
Q-EDDnp is glutamine (ethylenediamine(2,4-dinitrophenyl)),
the Z position was filled with 1 of 19 amino acids (cysteine was
omitted), and X represents randomly incorporated amino
acids.
Acyl-Biotin Exchange—To detect MCA4 palmitoylation, an
acyl-biotin exchange assay was used as described previously by
Emmer et al. (28).
N-terminal Edman Degradation—To sequence the N termi-
nus of processing products, reactions were set up as described
above, electrophoresed on NuPAGE Novex 10% BisTris gels
(Invitrogen), and transferred to a PVDFmembrane (Hybond-P,
Amersham Biosciences). Edman sequencing was performed by
the University of Dundee Medical Research Council Protein
Phosphorylation Unit.
Microscopy—Images were obtained using an Applied Preci-
sion DeltaVision Deconvolution microscope system fitted with
a CoolSnap HQ camera. Image capture and microscope opera-
tion were performed using the software package SoftWoRx.
Fluorescencewas viewed using the FITC filter (Ex 490 nm/Em
528 nm), and 4,6-diamidino-2-phenylindole (DAPI) filter (Ex
360 nm/Em 457 nm), and reference images were obtained
using the differential interference contrast filter. Exposure time
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was set to 1 s with the transmission level of the neutral filter
optimized for each sample, and 60 or 100 oil immersion
objectives were used. Typically, 15 Z-stacks were obtained and
individually deconvolved using the automatic conservative
ratio setting before projection into one representative image.
To merge images containing multiple fluorescent signals,
Adobe Photoshop was used. For direct cell fluorescence,1
105T. bruceiwere washed twice in trypanosome dilution buffer
(TDB) (20 mM Na2HPO4, 2 mM NaH2PO4, 80 mM NaCl, 5 mM
KCl, 1mMMgSO4, 20mM glucose, pH 7.4) before fixation in 1%
(w/v) paraformaldehyde (Sigma) with concurrent incubation
on ice for 15 min. After two further washes in TDB, the cell
pellet was resuspended in 20 l of TDB and evenly spread onto
twin frosted end 76 26-mmmicroscope slides coated in 0.1%
poly-L-lysine (Sigma), and the cells were allowed to sediment.
Excess liquid was removed, and the cells on each slide were
stained with 10 l of 1 g/ml DAPI in mounting solution (PBS,
50% (v/v) glycerol, 2.5% (w/v) DABCO). All slides were fitted
with a coverslip sealed with nail varnish.
ImmunofluorescenceAnalysis—Theprotocol used for immu-
nofluorescence analysis was adapted from the method pub-
lished by Field et al. (29). Briefly, mid-log bloodstream form
parasites werewashed in vPBS (137mMNaCl, 3mMKCl, 16mM
Na2HPO4, 3 mM KH2PO4, 46 mM sucrose, 10 mM glucose, pH
7.6) before fixation on ice in 3% paraformaldehyde for 10 min.
The fix solution was diluted out with excess vPBS, and two
further cell washes were performed. Fixed cells were applied to
a 2-cm2 area outlined in nail varnish on 0.1% poly-L-lysine-
treated microscope slides and allowed to sediment. When
required, the cells were permeabilized by applying 0.1% (v/v)
Triton X-100 in PBS for 10 min before washing with PBS and
blocking for 1 h using 20% (v/v) fetal calf serum (Sigma) in PBS.
Anti-MCA4 (1:400) diluted in blocking solution was applied
and incubated for 2 h at room temperature. Slides were washed
three times with PBS before one incubation with Alexa Fluor
488 (green)-conjugated anti-chicken (Molecular Probes)
diluted 1:7500 in blocking solution. Slides were washed three
times with PBS, stained with 1 g/ml DAPI in mounting solu-
tion, and sealed with a coverslip and nail varnish.
Immunoelectron Microscopy—A bloodstream form T. brucei
cell pellet was chemically fixed in suspension andmaintained in
0.2% (v/v) gluteraldehyde, 2% (w/v) paraformaldehyde in PBS
(pH 7.2) on ice for 1 h. After fixation, the cells were rinsed in
PBS and embedded in Lowicryl resin using the progressive low-
ering of the temperaturemethod. Cells were cut into blocks and
mounted on metal pins and frozen in liquid nitrogen before
sectioning with a Leica Ultracut UCT/FCS. The cryosections
were blocked with 0.1 M glycine followed by 5% (w/v) BSA and
then labeled with affinity-purified anti-MCA4 (1:10) and
1.4-nm gold (rabbit) anti-chicken (1:20) (Aurion). Cells were
contrast-stained, and the immunolabeling was enhanced by
15-min treatment with R-gent (Aurion). Sections were viewed
with a LEO 912 transmission electron microscope.
Cell Fractionation—The cellular fractionation method was
adapted from Ref. 30. For detergent lysis, 2 107 mid-log cells
were washed in vPBS and lysed in 500 l of 1% (v/v) Triton
X-100, 25 mM HEPES, 1 mM EDTA, pH 7.4, for 30 min on ice
before centrifugation at 14,000  g for 5 min. For hypotonic
lysis, 2 107 mid-log BSF cells were washed in vPBS and lysed
in 500 l of 10 mM Tris-HCl, pH 7.4, with four 15-s blasts in an
ice-cold sonicatingwater bath (Fisher FB15047), before centrif-
ugation at 14,000 g for 5 min. For both lysis methods, insol-
ublematerial in the pellet was solubilized by boiling with 625l
of 1 SDS-PAGE sample buffer for 5min. The supernatant was
prepared for electrophoresis by adding 125l of 4 SDS-PAGE
sample buffer and boiling for 5 min. 1  106 cell equivalents
were loaded per lane.
Motility Analysis—T. brucei resistance to sedimentation was
investigated as a function of cell motility (31). Wild type BSF
T. brucei and mca4 cells were cultured to the same mid-log
densities. 2 ml of culture was divided equally into two cuvettes,
and the A600 was recorded at the 0, 3, and 6 h time points. One
cuvette remained undisturbed, and the other was mixed and
resuspended before each optical density reading. Three repli-
cate experiments were performed, and sedimentation rates
were determined by subtracting the A600 of the undisturbed
control from the A600 of the resuspended culture.
MCA4 Release—To detect release ofMCA4, 1 108mid-log
T. brucei cells were washed in TDB and incubated at 37 °C in 15
ml of 50% serum-free HMI9, 50% TDB. Cell viability was mon-
itored every hour by hemocytometer count, and after 3.5 h, cells
were removed by centrifugation at 1500  g for 15 min.
Trypanosome-free medium was carefully aspirated, and Com-
plete Protease Inhibitor Mixture (Roche Applied Science) was
added to a final concentration of 1.5, before slow passage
through a 0.2-msyringe filter and 75-fold concentration using
a VivaSpin 20 10,000 molecular weight cut-off filter unit. The
concentrated supernatant was prepared for SDS-PAGE, and 35
l was loaded alongside whole cell lysate from 1  105 cells,
electrophoresed on a 12% SDS-PAGE, and then transferred to
nitrocellulose for Western blotting.
Statistical Analysis of Data—Where indicated, data were
expressed as means  S.D. p values were calculated using an
unpaired, two-tailed Student’s t test onMicrosoft Excel. Differ-
ences were considered significant at a p value of0.001.
RESULTS
MCA4 Is a Pseudopeptidase—The predicted active site of
MCA4maintains the canonical histidine residue but has serine
instead of the usual cysteine nucleophil (14, 15). Given the
highly specific nature of enzyme active sites, it seemed likely
that this substitution would make the peptidase inactive. How-
ever, other possibilities existed. First, it is possible that MCA4
functions as a mixed type peptidase utilizing the reactive
hydroxyl group of the serine as a nucleophile. Second, two cys-
teine residues widely conserved amongMCAs but located out-
side of the predicted active sitemay serve as alternative catalytic
residues; MCA4 Cys-98 is found in all MCAs, and MCA4 Cys-
218 is present in all kinetoplast MCAs (14, 32). Thus, we first
sought to establish whether or notMCA4 is an active peptidase
through analysis of the recombinant protein.
Previous work demonstrated that TbMCA2 undergoes rapid
calcium-dependent autocatalytic processing but that this is not
required for activity (2). MCA4 remained unprocessed in the
presence of calcium (Fig. 1A), and a range of peptide substrates
cleaved by MCA2, including Z-GGR-AMC, Z-GRR-AMC,
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Z-RR-AMC, and a peptide library containing all amino acids in
the P1 position, also failed to detect MCA4 activity. An
MCA4S219Cmutant, inwhich the active site serinewas replaced
with cysteine, was, however, capable of autoprocessing when
incubated with calcium (Fig. 1B). N-terminal Edman sequenc-
ing of themajor proteolytic processing product identified auto-
catalytic cleavage at Lys-64 (KESK64GFQPWK). Consistent
with metacaspase specificity toward basic residues in the P1
position, we found that MCA4S219C could also cleave the pep-
tide substrate Z-GGR-AMC, although at a rate greatly reduced
in comparisonwithMCA2 (MCA2, 11 3.0milliunits/mg pro-
tein; MCA4S219C, 0.031  0.0043 milliunits/mg protein).
MCA4S219C activity was similar to that of MCA2 in being
dependent on calcium and strongly inhibited by leupeptin and
antipain but only mildly inhibited by E64 (Fig. 1C). These data
collectively demonstrate that creation of the canonical meta-
caspase dyad in MCA4 produces a calcium-dependent proteo-
lytically active enzyme, confirming thatMCA4 has retained the
structure of active MCAs; the lack of peptidase activity, how-
ever, means that it is a pseudopeptidase.
RNAi Depletion of MCA4 Severely Restricts Parasite
Proliferation—Western blot analysis revealed that MCA4
expression has a distinct stage specificity, with the protein
being present in the bloodstream form but not detectable in the
procyclic formof the parasite (Fig. 2A). The antibody specificity
was confirmed by analysis of an MCA2, MCA3, MCA5 triple
null mutant (16), in which the immunopositive band was simi-
lar in intensity to that inwild type parasites (Fig. 2A). The size of
the MCA4 protein in the parasite extracts was very close to the
predicted 40-kDa molecular mass of the full-length protein,
showing that under standard in vitro growth conditions,MCA4
in the parasite was not subject to detectable proteolytic proc-
essing events.
This defined pattern of expression suggested an important
role specific to bloodstream forms, so in order to investigate
this, we characterized the effects of targeted RNAi down-regu-
lation of MCA4 in this life cycle stage. Following RNAi induc-
tion, a rapid growth arrest occurred at around 8 hwith only low
numbers of motile cells persisting over the remainder of the
RNAi time course (Fig. 2B). Western blot analysis was used to
verify the successful depletion of MCA4 (Fig. 2C). To analyze
the progression of RNAi-induced parasites through the cell
cycle, the configuration of nuclei (N) and kinetoplasts (K) was
determined by fluorescent microscopy of DAPI-stained cells
(Fig. 2D). The reduction of cells with one nucleus and one kin-
etoplast (1N1K cells) with increased 2N2K and abnormal cells
(classified as “others,” including those containing increased
DNA content and zoids) showed that induced cells were able to
replicate their DNA but failed to correctly execute cytokinesis.
The flow cytometry profiles of the induced cells confirmed the
DAPI analysis (supplemental Fig. S1). These RNAi data suggest
that MCA4 is essential for the normal proliferation of blood-
stream form T. brucei. This finding corroborates and expands
upon a similar observation following a genome-wide RNAi
silencing screen, which identified MCA4 as having a loss of
fitness phenotype (33).
An Important Role for MCA4 in Virulence—Previous work
demonstrated that simultaneous RNAi silencing of MCA2,
MCA3, and MCA5 was lethal to bloodstream form T. brucei,
yet the generation of triple null mutant cell lines was still pos-
sible (16). We found that this was also the case with MCA4
because MCA4 null mutants (mca4) were readily generated.
FIGURE 1.MCA4 andMCA4S219C peptidase activity. A, lack of calcium-dependent MCA4 autoprocessing (10 g) was analyzed by SDS-PAGE. B, calcium-de-
pendentMCA4S219C (10g) autoprocessingwas analyzed by SDS-PAGE. The N terminus of themajor processed product was sequenced (underlined), and the
processing site ismarkedwith an asterisk.C, cleavage of Z-GGR-AMCby 5gofMCA4S219Cwasmeasured under the conditions indicated, expressed as relative
value, and given as mean S.D. (error bars).
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MCA4and anumber ofmutantMCA4 re-expression lineswere
created through the introduction of specific amino acid
changes within MCA4 (designated mca4:MCA4, mca4:
MCA4G2A, andmca4:MCA4S219C). The validity of the genetic
manipulationwas confirmed by Southern blotting (supplemen-
tal Fig. S2), andWestern blotting was used to verify the absence
ofMCA4 inmca4 cells and to demonstrate that re-expression
occurred at a level equivalent to that in the wild type cells (Fig.
3A).
The initial growth rate of mca4 parasites in culture was
greatly reduced in comparison with the parental wild type
strain (supplemental Fig. S3). However, following several weeks
of continuous growth and subculturing, the growth rate of
mca4 recovered and DAPI analysis revealed that, unlike the
RNAi-induced cells, no major defects were detected in cell
cycle progression or motility (supplemental Fig. S3).
A potential role of MCA4 in the mammalian infection proc-
ess was investigated by comparing the infection profiles of wild
type andmutant parasites inmice. The wild type parasites were
highly virulent in mice and, by day 4, established parasitemia
above 108 cellsml1, whichwaswhen themicewere culled (Fig.
3, B and C). mca4 parasites, however, showed a drastically
different infection profile, with mouse survival prolonged to
around 15 days (Fig. 3B). The reduced in vivo growth rate of
MCA4-deficient parasites could be partially restored by the re-
expression of MCA4, with 75% of mice succumbing to mca4:
MCA4 infection by day 7. Axenic culture of parasites isolated
from mice at the first peak of parasitemia revealed normal
growth for all strains (supplemental Fig. S3), indicating that the
variation observed in vivo was due to interaction with the host.
Detailed analysis of the parasitemia patterns of the infected
mice revealed several interesting trends. Thewild type parasites
were extremely virulent, and the parasitemia increased very
rapidly (Fig. 3C). In contrast, mice infected with mca4 had a
peak of parasitemia separated by a trough period where para-
sitemia was below the detection threshold. In the re-expression
cell lines, the parasitemia profile wasmore similar to that of the
wild type cells, typified by consistent growth with only one
mouse per group being able to very briefly clear infection to
below the detection threshold (Fig. 3C).
MCA4Associates with the FlagellarMembrane—The cellular
localization of MCA4 was revealed by immunofluorescence
microscopy using affinity-purified, anti-MCA4 antibody (Fig.
4A). MCA4 was found to localize predominantly to the flagel-
lum, appearing as a combination of punctate structures and
larger confluent foci distributed along the entire length of the
flagellum. This was confirmed by re-expression of MCA4 with
a C-terminal YFP fusion in mca4 parasites, which also
revealed a distinct flagellum localization when viewed by direct
fluorescent microscopy. Immunogold transmission electron
microscopy studies provided further detailed evidence sup-
porting the punctate nature of MCA4 along the flagellum, with
FIGURE 2.MCA4 expression and analysis by RNAi. A, total cell lysates were prepared from T. brucei bloodstream form (lane 1) and procyclic form (lane 2) and
bloodstream formmca2/3mca5 (lane 3) and separated by SDS-PAGE beforeWestern blotting with anti-MCA4. An antibody specific to EF-1 demonstrates
equal loading. B, MCA4 RNAi in bloodstream form was induced by 1 g/ml tetracycline (Tet), and parasite growth rate was compared with non-induced
control (Tet). C, Western blot analysis ofMCA4protein level during RNAi time course.D, the effect ofMCA4 RNAi on cell cycle progressionwas determined by
assessing DNA configuration using DAPI staining and fluorescence microscopy.	200 cells were counted per time point. Cells at the start of the cycle with a
singlenucleus (N) andkinetoplast (K) are 1N1K. Kinetoplast divisionoccurs aheadofnucleardivision, leading to1N2Kcells beforepost-mitotic 2N2Kcells. Those
cells with abnormal DNA content are classified as “other.”
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the enhanced immunogold particles appearing in clusters at
unmarked but distinct foci along the internal surface of the
flagellum (Fig. 4B).
The T. brucei flagellum is a complex organelle composed of
multiple distinct structures. To gain potential insights into
MCA4 function, the precise location within the flagellum was
assessed using a subcellular fractionation procedure capable of
distinguishing between soluble, cytoskeletal, and membrane-
associated proteins. Western blot analysis of T. brucei subcel-
lular fractions demonstrated that MCA4 was a membrane-as-
sociated protein, being found in the pellet of the hypotonic and
sonicated cell lysate and the soluble fraction of the detergent-
treated cell lysate (Fig. 5A). To verify the quality of the fraction-
ation procedure, the different fractions were probed with anti-
bodies specific to the cytoskeletal protein -tubulin and the
cytoplasmic protein oligopeptidase B. To determine whether
MCA4 was located on the internal or external surface of the
flagellarmembrane, immunofluorescencemicroscopywas per-
formed in the presence and absence of Triton X-100 (Fig. 4A).
The stronger staining of the flagellum was detected in those
cells treatedwith detergent, suggesting that theMCA4 epitopes
were mainly internally located and required permeabilization
for exposure.
No single flagellum-targeting sequence has been identified
for T. brucei; however, dual acylation has been shown to influ-
ence the flagellar membrane association of several proteins (28,
34, 35). Previous comprehensive bioinformatic screens identi-
fied MCA4 Gly-2 as a target for N-myristoylation (36), a mod-
ification often associated with palmitoylation. Accordingly, we
attempted to provide experimental evidence of in vivo MCA4
FIGURE 3.Analysis of bloodstream formMCA4nullmutants. A, Western blot ofmca4 and re-expression cell lines. Lane 1, T. brucei 427; lane 2,mca4; lane
3, mca4:MCA4; lane 4, mca4:MCA4G2A; lane 5, mca4:MCA4S219C. B, groups of four mice were infected with 3  105 parasites, and mouse survival was
monitored daily and is shown by a Kaplan-Meier survival curve. C, mice were infected with 3 105 parasites, and parasitemia wasmonitored by tail prick and
hemocytometer cell count. Mice were culled when parasitemia reached	1 108 cells/ml or upon presentation of severe symptoms.
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palmitoylation using an acyl-biotin exchange reaction (28).
Western blotting ofmaterial from the experimental and control
reactions revealed thatMCA4was purified in a hydroxylamine-
dependent manner from T. brucei cell lysate, confirming that
the proteinwas palmitoylated in vivo (Fig. 5B). This experimen-
tal finding combined with the bioinformatic predictions sug-
gests that MCA4 is dually acylated.
The influence of acylation on MCA4 localization was inves-
tigated by creation of a MCA4G2A mutation that was predicted
to prevent N-myristoylation and consequently palmitoylation.
MCA4G2A was re-expressed in mca4 parasites, and fraction-
ation of the mca4:MCA4G2A parasites revealed that
MCA4G2A appeared in the soluble material following hypo-
tonic lysis (Fig. 5A). Immunofluorescent analysis of themca4:
MCA4G2A mutants showed that MCA4G2A was dispersed
throughout the cytoplasm and absent from the flagellum (Fig.
4A). Infection ofmice withmca4:MCA4G2A parasites demon-
strated complementation of the mca4 phenotype, indicating
that under the condition tested, flagellar membrane localiza-
tion of MCA4 is not essential for an effect on the parasite’s
virulence (Fig. 3, B and C).
Processing of MCA4 and Release—Previous work identified
MCA4 as part of the secretome of two independent T. brucei
gambiense strains (37). We therefore tried to provide indepen-
dent verification of a similar occurrence in T. brucei. Cultured
mid-log phase bloodstream form parasites were incubated in
FIGURE 4. Localization of MCA4 in bloodstream form trypanosomes. A, immunofluorescence. Cells were permeabilized with Triton X-100 or left intact,
before incubationwith anti-MCA4 antibody and anti-chicken Alexa Fluor 488 conjugate, visualized using the FITC filter set (green). DNAwas stainedwith DAPI
(blue), and reference imageswere takenwithdifferential interference contrast filter settings.mca4:YFP-MCA4 cellswere analyzedbydirect fluorescenceusing
the FITC filter set (green). Scale bars, 5m. B, MCA4 immunogold transmission electronmicroscopy. Fixed cellswere cryosectioned and labeledwith anti-MCA4
and 1.4-nm gold-conjugated rabbit anti-chicken. Black arrowheads, enhanced immunogold particles. Lower left image, digitally magnified section of the
corresponding image above; arrowheads labeled a and b are labeled a and b in the magnified section.
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serum-free medium for 3.5 h before removal by centrifugation.
The resulting parasite-free mediumwas concentrated and ana-
lyzed alongside whole cell lysate by Western blot. MCA4 was
clearly evident in the released material, appearing as different
sized proteins: a highermolecularmass species (identical in size
to the protein detected in cell lysate) and two smaller less abun-
dant processed forms (Fig. 6A). Nonspecific protein accumula-
tion in the medium was analyzed by probing the blot with anti-
BiP, which is largely retained intracellularly (38). In comparison
with the parasite lysate, only small amounts of BiP were
detected in the released material (Fig. 6A). MCA4 release was
detected in both mca4:MCA4 and mca4:MCA4G2A cell
lines, revealing that MCA4 release occurred independently of
flagellar membrane localization (Fig. 6A). One key finding,
however, was the absence of any processed MCA4 protein in
the material released from mca4:MCA4G2A cells. This
excluded the possibility of random degradation of MCA4
occurring in the medium and suggested a specific proteolytic
event dependent upon association of MCA4 with the flagellar
membrane.
To test if one of the other TbMCAs might be responsible for
MCA4 processing, we analyzed material released from
mca2/3 mca5 parasites (16) and found that only full-length
MCA4 could be detected. We analyzed individual re-expressor
cell lines and identified MCA3 as the major peptidase respon-
sible for MCA4 processing (Fig. 6A). MCA2 and MCA3 pro-
teins share 89% sequence identity with nearly identical catalytic
domains and divergence only found at the N terminus (15, 16),
a difference that does not appear to alter the enzyme’s substrate
specificity (supplemental Fig. S4). Thus, it was intriguing that in
vivo processing ofMCA4 was mediated only byMCA3. To rule
out the possibility that MCA4 is resistant to MCA2 proteolytic
activity, we incubated recombinant MCA4 with MCA2 (2:1
molar ratio) and, having confirmed that it had no significant
impact on MCA2 activity, showed that recombinant MCA2
processed MCA4 with a pattern of cleavage similar to that of
the autocatalytic processing by MCA4S219C (compare Figs. 6B
and 1B). N-terminal Edman degradation revealed that process-
ing occurred at Lys-64, the same residue cleaved during auto-
catalytic processing of recombinant MCA4S219C (Figs. 1B and
6B). These data suggest that the selective in vivo proteolytic
cleavage ofMCA4 byMCA3must be due to reasons other than
specificity per se and provide direct evidence that there is co-
localization of and interaction between these T. brucei MCAs
in a proteolytic cascade, resulting in release of the
pseudopeptidase.
DISCUSSION
The active site residues of metacaspases have been identified
through sequence alignment and homology with caspases, fol-
lowed in some cases by experimental verification (2, 4). The
predicted active site ofMCA4 is of particular interest due to the
presence of a potential serine nucleophilewithin a cysteine pep-
tidase. Here we demonstrate, however, that MCA4 does not
have autocatalytic activity or activity toward a range of peptide
substrates, ruling out the possibility that it functions as amixed
type peptidase or that catalytic activity can be derived from
other conserved cysteine residues. Nevertheless, by using
mutagenesis to reinstate a canonicalmetacaspase active site, we
have shown thatMCA4S219C has calcium-dependentMCA-like
activity, and consequently the native protein has retained a
functional peptidase tertiary structure. In light of these find-
ings, we speculate that the active site cysteinewasmutated in an
ancestral MCA, generating the pseudopeptidase MCA4, which
now fulfills an important role for the parasite.
Targeted RNAi down-regulation indicated that MCA4 is
essential for bloodstream form cell proliferation. At 24 h post-
induction, abnormal cell types accumulated, which is indicative
of a post-mitotic block and linksMCA4 to a role in cytokinesis.
However, theMCA4 RNAimutants broadly conform to a com-
mon phenotype associated with the RNAi down-regulation of
key bloodstream form flagellar proteins (39). Therefore, given
the flagellar membrane association that we have demonstrated
for MCA4, we predict that MCA4 is more likely to exert its
effect on cytokinesis indirectly.
The implied essentiality of MCA4 following RNAi down-
regulation strongly suggested that the gene would be refractory
to genetic deletion. However, MCA4 was successfully deleted
from bloodstream form cells creating viable null mutant para-
sites (mca4). We attribute this apparent discrepancy to the
FIGURE 5. Subcellular fractionation and modification of MCA4 in bloodstream form trypanosomes. A, cell fractionation. Total cell lysate (T), detergent-
soluble (DS), detergent pellet (DP), hypotonic soluble (HS), and hypotonic pellet (HP) fractions were analyzed by Western blot using anti-MCA4 antibody. The
quality of fractionationwas validatedwith antibodies specific to-tubulin andoligopeptidaseB (OPB).B, acyl-biotin exchange reaction. Palmitoylatedproteins
were specifically labeled by cleaving palmitate-thioester bonds with hydroxylamine and subsequently reacted with biotin-HPDP (N-[6-(biotinamido)hexyl]-
3-(2-pyridyldithio)propionamide), allowing purification with streptavidin-agarose. Original cell lysate (I), the wash fraction (W), and eluted material (E) from
hydroxylamine-treated and Tris control samples were immunoblotted with anti-MCA4 antibody.
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differing dynamics of MCA4 depletion associated with each
technique. RNAi of MCA4 leads to rapid removal of the pro-
tein, preventing parasite adaptation, whereas the sequential
replacement of each allele during creation of the null mutants
provides sufficient time for parasite adjustment to diminishing
MCA4 levels. This adaptation in null mutants has also been
described formca2/3mca5 parasites (16). In that instance, it
was suggested that MCA4may be an alternative compensatory
biochemical pathway following the deletion of MCA2, MCA3,
and MCA5. However, given the absence of MCA4 activity and
the markedly different localization, this now appears unlikely.
The ancestral MCA homologue in T. brucei is likely to be
MCA5, given its synteny with the single L. major MCA. This
raises the question of whether MCA function differs between
organismswith a singlemetacaspase (such as budding yeast and
L. major) and organisms with multiple MCAs (T. brucei and
A. thaliana). MCA2, MCA3, and MCA4 are all expressed at a
higher level in the bloodstream form of the parasite than in the
procyclic form, whereasMCA5 is expressed equally in both life
cycle stages (16) (this work). Accordingly, we speculated that
MCA4 could be involved in trypanosome-specific functions
associated with mammalian infectivity. Indeed, infection of
mice with wild type T. brucei and mca4 cell lines revealed
strikingly different patterns of infection, with mca4 cells
showing periods below the detection threshold and consecutive
days of reduced parasite burdens more similar to pleomorphic
bloodstream form strains than to the parental highly virulent
monomorphic 427 strain. This resulted in amarkedly extended
survival time for the host mice and revealed a role forMCA4 in
parasite virulence within the mammalian host.
Our data, together with a recent characterization of the fla-
gellum proteome (40), have identified a flagellum localization
for MCA4. Several other flagellar proteins have also been
shown to influence T. brucei virulence in mice. The deletion of
the glycosylphosphatidylinositol-phospholipase C created a
prolonged infection in mice that was accompanied by multiple
peaks and troughs of parasitemia (41). In addition, in vivoRNAi
silencing of the calflagins (Tb17, Tb24, and Tb44) prolonged
mouse survival by attenuating parasite growth, creating an
infection with waves of parasitemia associated with the expres-
sion of alternative variant surface glycoproteins (42). Although
not confirmed experimentally, it seems likely that the reduced
virulence of mca4 allowed the host’s immune system suffi-
cient time to clear the original infection before the re-emer-
gence of cells expressing a different VSG type.
Regulated proteolytic activity is an important mechanism of
signal transduction used by peptidases to modify properties of
substrate proteins. The strict specificity displayed by many
Clan CD peptidases is dictated by a highly selective S1 pocket,
which ensures that they are well adapted to carry out specific
processing events and less suited to perform random proteo-
lytic degradation. This is well demonstrated by the many com-
plex and intricate signaling pathways involving caspases during
their participation in apoptosis and inflammation (43). Indeed,
related processes have recently been reported for anMCA from
P. abies (mcII-Pa) that was shown to inactivate a Tudor staph-
FIGURE 6.MCA4 release and proteolytic processing by MCA3. A, detection of MCA4 in released material. Cells were incubated in serum-free medium and
then removed by centrifugation before concentration of cell free fraction and analysis by Western blot. Total cell lysate (T) and released material (R) were
probed with anti-MCA4. The blot was stripped and reprobed with anti-BiP. B, MCA4 processing by MCA2 was analyzed by SDS-PAGE. The N terminus of the
major processed product was sequenced, six amino acids were identified (underlined), and the cleavage site was marked with an asterisk. RB, reaction buffer.
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ylococcal nuclease protein through cleavage at four defined
sites during programmed cell death events associated with
embryogenesis and oxidative stress (6). However, whether this
represents a highly specific form of signal transduction, as wit-
nessed for capsases, is open to somedebate (8).Our observation
thatMCA3 processesMCA4 provides the first identification of
an in vivo T. brucei MCA substrate, which is only the second
MCA substrate to be identified, after Tudor staphylococcal
nuclease (6). Although the biological significance of MCA4
processing is unknown, this cleavage event establishes an
important link between twoMCAs thatmay be a component of
a broaderMCA cascade.Moreover, the proteolytic inactivity of
MCA4 suggests that it lies at the end of any such proteolytic
cascade. This arrangement, wherebyMCA4 is placed under the
control of MCA3, may optimize release and action of MCA4 in
a highly regulated manner.
The major form of MCA4 detected after release from the
parasite was similar in size to the full-length protein, but less
abundant lower molecular mass forms were also detected.
Because re-expression of MCA4G2A in mca4 resulted in the
release of only the full-length protein, processing of MCA4 is
clearly dependent upon correctmembrane localization andwas
not the product of random degradation or autocatalytic activ-
ity. Our finding that MCA3 processes MCA4 is particularly
relevant because MCA3 has been reported to be present in
RAB11-positive endosomes/exosomes (16) and the flagellum
proteome (40) and is the only other T. brucei MCA that is
palmitoylated (35). These data suggest that there must be some
crossover between the exosome membranes and the flagellum,
at which point MCA4 is processed and released. We have also
shown that lipidation is crucial in allowing direct interaction
between MCA3 and MCA4 on the membrane. However, this
interaction at the membrane is not essential for the release of
MCA4 because the non-lipidated mutant is also released, pos-
sibly via an alternative route.
The way in which MCA4 exerts its influence upon infection
in a mammalian host remains to be established, but the recent
proposal that exosome release, by both intracellular and extra-
cellular pathogens, can allow effector molecule delivery to host
cell cytosol (44) provides a possible mechanism for delivery of
trypanosome virulence factors (45). Our finding that MCA4 is
released by bloodstream form T. brucei and does not appear to
influence the processing or activity of otherMCAs opens up the
possibility that it could target and regulate host molecules.
Future investigation of T. brucei strains that establish natural
chronic infections could help to identify potentialMCA4 inter-
actions and allow further clarification of its role in parasite
virulence.
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